Saturday, July 25, 2026
In Detail Full day, Saturday, July 25, 2026, Timezone: America/Chicago
US court rules abortion pill restrictions 'unlawful'
medicalxpress - A federal court in Virginia has ruled that restrictions imposed by the U.S. drug regulator on the abortion pill mifepristone are "unlawful" and ordered the Trump administration to reconsider them.
AI Summary: A U.S. court ruled recent restrictions on the abortion pill unlawful, reaffirming FDA regulatory standards and restoring broader access. Industry groups filed briefs backing FDA oversight, warning that legal uncertainty would harm patients and research. The ruling calms access for now while legal and policy debates continue.
The AACR Rare Cancers Initiative: Uniting Researchers, Undoing Barriers, and Unleashing Progress
Steve Schneible / aacr - At the recent AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers, AACR Immediate Past President Lillian L. Siu, MD, FAACR, announced the AACR Rare Cancers Initiative. Learn more about how this new Initiative will marshal global…
AI Summary: The AACR has unveiled a Rare Cancers Initiative to coordinate researchers, streamline data sharing, and speed therapeutic development for uncommon tumor types. By pooling expertise, funding and networks, the program seeks to overcome the chronic scarcity of trials and resources that leave rare‑cancer patients waiting for attention that’s been hard to come by.
Breathalyzer can 'sniff out' when your body starts burning fat
medicalxpress - Researchers have developed a breath detector with a chemical sensor that sniffs out when your body is burning fat through a single exhale. Reporting in Device, the handheld, smartphone-assisted device measures acetone—a molecule that is released into the …
AI Summary: Engineers developed a breath-based detector that pinpoints when the body shifts to fat oxidation, and shrank it down to a phone-compatible breathalyser. The device measures volatile markers in exhaled breath to indicate metabolic state, enabling noninvasive, real‑time monitoring of fat burning for weight-loss or metabolic research — because your phone now judges your dinner choices.
Gregory Lesinski: Winship Team Publishes Novel CAR/VIPRa T-Cell Therapy in Science
oncodaily - Gregory Lesinski, Associate Director of Basic Research at Winship Cancer Institute of Emory University, shared on LinkedIn by Sarwish Rafiq, Assistant Professor at the Emory University School of Medicine and […]
AI Summary: Researchers published a novel CAR T‑cell approach exploiting the VIP–VIPR pathway that reprograms cells for superior antitumor activity in preclinical models. The Winship team’s paper reports enhanced tumor killing and durability in laboratory studies, flagging a promising route to improve CAR T efficacy in solid tumors — still very early, but intriguing.
Molina Healthcare plans more marketplace exits as ACA segment falters
fiercehealthcare - Molina Healthcare is planning further reductions in its marketplace business as high costs continue to pressure that segment, the company's top brass told investors on Thursday morning.
AI Summary: Molina Healthcare announced plans to withdraw from additional Affordable Care Act marketplaces, citing financial challenges and market pressures. The move signals growing instability for some insurers in the ACA exchange space and could limit options for consumers in affected regions, while reigniting debates about market design and access.
- Hospitals and employers feel squeeze as uninsured rates climb (4)
- Insurers retreat from ACA exchanges, sparking debate over causes (4)
Hospitals and employers feel squeeze as uninsured rates climb
Insurers retreat from ACA exchanges, sparking debate over causes
Could this enzyme help remove 'zombie' cells from our tissues?
medicalxpress - Our population is aging. The United Nations reports that by 2050, the number of people age 85 and older on our planet is set to triple. But a longer life span isn't the same as a longer health span (the number of years we spend healthy). Salk Institute sc…
AI Summary: Researchers identified an enzyme that selectively targets senescent “zombie” cells, restoring tissue function in preclinical models and hinting at anti‑aging and therapeutic possibilities. The findings generated excitement for potential disease‑modifying strategies, but experts caution that translating enzyme‑based fixes from mice to humans will require careful safety studies and sober expectations.
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial
Adam D. Cohen / nature - Nature Medicine, Published online: 22 July 2026; doi:10.1038/s41591-026-04522-3In a phase 1 trial, the maximum tolerated dose for an FcRH5-containing bispecific T cell engager was not reached, and there was an encouraging response rate in patients with re…
AI Summary: A phase 1 study of the FcRH5×CD3 bispecific antibody cevostamab reported manageable safety and early signals of activity in relapsed or refractory multiple myeloma. Investigators outlined dosing, adverse events and preliminary responses, setting the stage for larger studies and combination trials as patients and advocates watch for broader access to T‑cell‑engaging therapies.
$10B M&A Deal Pays Off With GSK’s First Lung Cancer Drug Approval
Frank Vinluan / medcitynews - GSK drug Jideytro received FDA approval for treating advanced cases of non-small cell lung cancer driven by ROS1 alterations. This molecule came from Nuvalent, which GSK recently acquired for $10.6 billion. The post $10B M&A Deal Pays Off With GSK’s First…
AI Summary: GSK has won FDA approval for its first lung cancer drug, a gene-targeting therapy that validates the company’s heavy investment and recent M&A strategy. The approval follows pivotal trial evidence of clinical benefit and positions GSK competitively in thoracic oncology, offering a new therapeutic choice for patients with the relevant molecular profile.
US actions harm global efforts to prevent and treat HIV in dozens of countries, new report says
medicalxpress - The Trump administration's disruptions to a global AIDS relief program have forced organizations to close clinics, lay off staff and cut services, seriously impeding efforts to prevent and treat the disease in dozens of countries, a new report released Tu…
AI Summary: A new analysis concludes recent U.S. policy shifts have weakened international HIV prevention and treatment initiatives, disrupting funding flows and partnership stability. Public health experts caution the changes could reverse progress in vulnerable regions, urging policymakers to recalibrate support to sustain global gains against HIV/AIDS.
Teladoc Health unveils new virtual care model for employers, health plans that ties payment to results
fiercehealthcare - Teladoc Health unveiled a new virtual care model for employers and health plans designed to offer a more coordinated, personalized approach for members, while tying payment to clinical and financial outcomes.
AI Summary: Teladoc unveiled a new virtual care model tying payment to outcomes for employers and health plans, a shift toward value‑based digital services. The initiative aims to improve quality and lower costs, with performance metrics determining reimbursement. Payers and employers will watch closely to see if digital results match the sales pitch.
Children's cereals promise breakfast fun and nutrition, but are still high in sugar
medicalxpress - Many of us have grown up hearing the mantra that breakfast is the most important meal of the day, yet children's cereals fall short of that standard. That is the takeaway of new research analyzing child-targeted cereals in Canada.
AI Summary: Two investigative reports show major children's breakfast cereals remain high in added sugars despite branding that implies nutrition and fun. Public health advocates warn the products contribute to unhealthy diets in kids and call for clearer labeling and stricter marketing standards to parents and regulators.
D.C. appeals court sides with HHS in 340B drug discount program rebate challenge
fiercehealthcare - The ruling upheld a previous decision that pharma companies cannot impose rebates without HHS Secretary approval.
AI Summary: The D.C. appeals court sided with HHS in a legal challenge over 340B drug discount rebates, affirming federal authority over the program’s rebate models. The ruling preserves HHS policy changes that influence pricing and hospital participation, potentially reshaping pharmacy discounts and provider finances nationwide.
- Appeals court and federal rulings cement HHS 340B authority (3)
- CMS reimbursement shakeup: winners, losers and litigation fallout (3)
- HRSA’s revised 340B rebate pilot and oversight push (3)
Appeals court and federal rulings cement HHS 340B authority
CMS reimbursement shakeup: winners, losers and litigation fallout
HRSA’s revised 340B rebate pilot and oversight push
6-year-old in China dies after experimental treatment, investigation finds, raising questions about the country's gene therapy regulations
livescience - A young girl in China died after being given an experimental gene therapy intended to treat a neurodevelopmental syndrome, an investigation by Science and Retraction Watch revealed.
AI Summary: An investigation found a six‑year‑old patient died following an experimental gene‑editing treatment in China, and that the fatality was not promptly disclosed. The case has reignited scrutiny of the country’s gene therapy oversight and raised urgent questions about trial transparency, consent and regulatory enforcement.
1.6 Million Egg Cartons Are Recalled Over Salmonella Risk
Alena Cerro / nytimes - The voluntary recall included eggs produced in Texas and sold under several brand names in six states, the Food and Drug Administration said.
AI Summary: The USDA-ordered recall removes roughly 1.6 million cartons (about 1.6 million dozen) of eggs after Salmonella contamination concerns surfaced. Retailers have been instructed to pull affected lots and consumers advised to discard or return suspect products. Regulators and producers are scrambling to trace the source and contain potential outbreaks.
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Autism, FDA, Trump Administration, Avian Influenza and look for the RSS link.
StackHealth Time Machine
More StackHealth